Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials

Area of Science:

• Cardiology
• Pulmonology
• Infectious Diseases
• Clinical Trials

Background:

• The COVID-19 pandemic necessitated rapid development of effective therapeutic strategies.
• Host tissue-directed medical interventions were explored to improve patient outcomes.
• Multisite clinical trials were crucial for evaluating diverse treatment options.

Purpose of the Study:

• To describe the Collaborating Network of Networks for Evaluating Covid-19 and Therapeutic Strategies (CONNECTS) research program.
• To report on the enrollment, interventions evaluated, and lessons learned from large-scale COVID-19 therapeutic trials.
• To assess the efficiency and challenges of executing multisite clinical trials during a pandemic.

Main Methods:

• The CONNECTS program involved five multisite clinical trials.
• 6690 participants were enrolled across outpatient, inpatient, and post-discharge settings.
• 18 intervention strategies using 10 molecular agents were evaluated using adaptive platform designs.

Main Results:

• Rapid trial execution was achieved through extensive collaboration and flexible, adaptive designs.
• The program successfully evaluated a broad range of therapeutic interventions for COVID-19.
• Key challenges included administrative delays, workforce constraints, and limited nonacademic research infrastructure.

Conclusions:

• Collaborative networks and adaptive platform designs are effective for rapid clinical trial execution during public health emergencies.
• Addressing operational challenges is crucial for optimizing efficiency in large-scale clinical research.
• The CONNECTS initiative provides valuable insights for future pandemic preparedness and response strategies.